156 related articles for article (PubMed ID: 31962336)
1. Tumor Sidedness Is Associated with Survival in Patients with Synchronous Colorectal Peritoneal Carcinomatosis.
Matsuda K; Tamura K; Iwamoto H; Mizumoto Y; Mitani Y; Nakamura Y; Murakami D; Sakanaka T; Yamaue H
Oncology; 2020; 98(4):230-236. PubMed ID: 31962336
[TBL] [Abstract][Full Text] [Related]
2. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
[TBL] [Abstract][Full Text] [Related]
3. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
Klaver YL; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
[TBL] [Abstract][Full Text] [Related]
4. Clinical impact of a macroscopically complete resection of colorectal cancer with peritoneal carcinomatosis.
Matsuda K; Hotta T; Takifuji K; Yamamoto M; Nasu T; Togo N; Oka M; Tabuse K; Yamaue H
Surgery; 2012 Feb; 151(2):238-44. PubMed ID: 21176934
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study.
Shida D; Tanabe T; Boku N; Takashima A; Yoshida T; Tsukamoto S; Kanemitsu Y
Ann Surg Oncol; 2019 May; 26(5):1358-1365. PubMed ID: 30719633
[TBL] [Abstract][Full Text] [Related]
6. Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer F; Thaler J; Piringer G; Hackl H; Pleyer L; Hufnagl C; Weiss L; Greil R
BMC Cancer; 2018 Jan; 18(1):11. PubMed ID: 29298682
[TBL] [Abstract][Full Text] [Related]
7. Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score.
Gasser E; Braunwarth E; Riedmann M; Cardini B; Fadinger N; Presl J; Klieser E; Ellmerer P; Dupré A; Imai K; Malik H; Baba H; Ulmer H; Schneeberger S; Öfner D; Dinnewitzer A; Stättner S; Primavesi F
PLoS One; 2019; 14(5):e0217411. PubMed ID: 31150437
[TBL] [Abstract][Full Text] [Related]
8. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
Hentzen JEKR; Rovers KP; Kuipers H; van der Plas WY; Been LB; Hoogwater FJH; van Ginkel RJ; Hemmer PHJ; van Dam GM; de Hingh IHJT; Kruijff S
Ann Surg Oncol; 2019 Jul; 26(7):2210-2221. PubMed ID: 30877495
[TBL] [Abstract][Full Text] [Related]
9. Incidence and prognosis of synchronous colorectal carcinomatosis.
Goéré D; Allard MA; Honoré C; Dumont F; Elias D
Future Oncol; 2013 Apr; 9(4):541-9. PubMed ID: 23560376
[TBL] [Abstract][Full Text] [Related]
10. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Solomon D; DeNicola NL; Feferman Y; Bekhor E; Reppucci ML; Feingold D; Aycart SN; Magge DR; Golas BJ; Labow DM; Sarpel U
Ann Surg Oncol; 2019 Mar; 26(3):845-851. PubMed ID: 30643994
[TBL] [Abstract][Full Text] [Related]
11. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
[TBL] [Abstract][Full Text] [Related]
12. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
Carmignani CP; Ortega-Perez G; Sugarbaker PH
Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
[TBL] [Abstract][Full Text] [Related]
13. Is primary sidedness a prognostic factor in patients with resected colon cancer liver metastases (CLM)?
Marques MC; C Ribeiro HS; Costa WL; de Jesus VHF; de Macedo MP; Diniz AL; Godoy AL; Farias IC; Aguiar S; Riechelmann RSP; S Begnami MDF; Coimbra FJF
J Surg Oncol; 2018 Apr; 117(5):858-863. PubMed ID: 29611198
[TBL] [Abstract][Full Text] [Related]
14. [The status analysis of diagnosis and treatment of synchronous peritoneal carcinomatosis from colorectal cancer in China: a report of 1 003 cases in 16 domestic medical centers].
Wang HM; Wang GY; Huang Y; Ren L; Zhang H; Wu AW; Han JG; Shu XG; Wang GY; Yang YC; Wang ZQ; Cui M; Lu Y; Feng B; Zhou JP; Wu B; Tong WD; Wang H; Luo YX; Wu XJ; Cai J; Yao HW; Wang L
Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):666-672. PubMed ID: 31474058
[No Abstract] [Full Text] [Related]
15. The modified Glasgow prognostic score for early mortality in patients with synchronous peritoneal carcinomatosis from colorectal cancer.
Adachi T; Hinoi T; Hattori M; Egi H; Shimomura M; Saito Y; Sawada H; Miguchi M; Niitsu H; Mukai S; Yano T; Ohdan H
Surg Today; 2015 Nov; 45(11):1396-403. PubMed ID: 25430811
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study.
Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S
BMC Cancer; 2022 May; 22(1):486. PubMed ID: 35501727
[TBL] [Abstract][Full Text] [Related]
17. Curative cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis and synchronous resectable liver metastases arising from colorectal cancer.
Lorimier G; Linot B; Paillocher N; Dupoiron D; Verrièle V; Wernert R; Hamy A; Capitain O
Eur J Surg Oncol; 2017 Jan; 43(1):150-158. PubMed ID: 27839895
[TBL] [Abstract][Full Text] [Related]
18. Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
Kotha NV; Baumgartner JM; Veerapong J; Cloyd JM; Ahmed A; Grotz TE; Leiting JL; Fournier K; Lee AJ; Dineen SP; Dessureault S; Clarke C; Mogal H; Zaidi MY; Russell MC; Patel SH; Sussman JJ; Dhar V; Lambert LA; Hendrix RJ; Abbott DE; Pokrzywa C; Lafaro K; Lee B; Greer JB; Fackche N; Lowy AM; Kelly KJ
Ann Surg Oncol; 2019 Jul; 26(7):2234-2240. PubMed ID: 31016486
[TBL] [Abstract][Full Text] [Related]
19. Prior Surgical Score: An Analysis of the Prognostic Significance of an Initial Nondefinitive Surgical Intervention in Patients With Peritoneal Carcinomatosis of a Colorectal Origin Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy.
Paul BK; Ihemelandu C; Sugarbaker PH
Dis Colon Rectum; 2018 Mar; 61(3):347-354. PubMed ID: 29420428
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome of up-front surgery in patients with asymptomatic, incurable synchronous peritoneal carcinomatosis.
Matsuda K; Hotta T; Takifuji K; Yokoyama S; Oku Y; Hashimoto T; Iwamoto H; Yamaue H
Surg Today; 2013 Sep; 43(9):984-9. PubMed ID: 23052739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
